3SBio and Alexandria Venture Investments have both contributed to a $50m round raised by Verseau, which is developing immunotherapies based on MIT research.

Strategic partner 3SBio and Alexandria Venture Investments have both contributed to a $50m round raised by Verseau that was disclosed as it emerged from stealth.

The care provider is supplying $50m for its Translational Innovation Fund while $30m is reserved for its Artificial Intelligence and Digital Translation Fund.

M Ventures participated in a $28m round completed by Plexium, which is working on small molecule drugs to treat cancer or neurodegenerative diseases.

Amgen and Illumina-backed genetic sequencing technology developer Oxford Nanopore is reportedly eyeing a $2.1bn private placement.

Tencent has led a series E-plus round for Taimei as part of a capital influx totalling $212m, with SoftBank's SBCVC unit also among the investors.

Yeshiva University’s Innovation Lab accelerator has more than doubled the number participating in its latest cohort, with a number of AI-driven technologies among those selected.

Oxford Nanopore is reportedly eyeing a $2.1bn private placement that could offer an exit to Woodford Investment Management.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.